Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-01-20 @ 6:30 AM
Study NCT ID:
NCT05217069
Status:
COMPLETED
Last Update Posted:
2025-04-16
First Post:
2019-01-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC
Sponsor:
Organization: